I-Fan Shih1, Zeyan Liew1, Niklas Krause2, Beate Ritz3. 1. Department of Epidemiology, Fielding School of Public Health, University of California at Los Angeles, California, USA. 2. Department of Epidemiology, Fielding School of Public Health, University of California at Los Angeles, California, USA; Department of Environmental Health Sciences, Fielding School of Public Health, University of California at Los Angeles, California, USA. 3. Department of Epidemiology, Fielding School of Public Health, University of California at Los Angeles, California, USA; Department of Neurology, School of Medicine, University of California at Los Angeles, California, USA. Electronic address: britz@ucla.edu.
Abstract
INTRODUCTION: While regular exercise has been shown to alleviate the motor symptoms of Parkinson's disease (PD), it remains unclear whether a physically active lifestyle may prevent PD. METHODS: To examine physical activities across the lifespan and risk of PD, we relied on data from a population-based case-control study that enrolled 357 incident PD cases and 341 controls. We assessed physical activity levels via self-report of (1) overall physical activity (PA) over 4 age periods; (2) competitive sports; and (3) occupational histories. RESULTS: PD risks were lower comparing the overall PA highest quartile (moderate to vigorous activities ≥180 metabolic equivalent task-hours/week (MET-h/wk)) with the lowest quartile (<47.8 MET-h/wk) in age-period 18-24 years (adjusted odds ratio (OR) 0.64, 95% confidence interval (CI) 0.40-1.02), and 45-64 years (OR 0.50, 95%CI 0.31-0.83) but not in age-period 25-44. Individuals who consistently engaged in overall PA at high levels (before age 65 years) had a 51% lower PD risk than those with low levels. Also, having participated in competitive sports prior to age 25 was inversely associated with PD (OR 0.53, 95% CI 0.31-0.91 for high level versus never). There was no association for measures of occupational physical activity though. CONCLUSION: The long prodromal stage of PD makes it difficult to conclude whether insidious disease leads to a reduction of physical activity years before motor symptom onset and PD diagnosis. However, sports activities and high levels of overall PA in youth appear protective unless they are markers for biologic or genetic factors that lower PD risk.
INTRODUCTION: While regular exercise has been shown to alleviate the motor symptoms of Parkinson's disease (PD), it remains unclear whether a physically active lifestyle may prevent PD. METHODS: To examine physical activities across the lifespan and risk of PD, we relied on data from a population-based case-control study that enrolled 357 incident PD cases and 341 controls. We assessed physical activity levels via self-report of (1) overall physical activity (PA) over 4 age periods; (2) competitive sports; and (3) occupational histories. RESULTS:PD risks were lower comparing the overall PA highest quartile (moderate to vigorous activities ≥180 metabolic equivalent task-hours/week (MET-h/wk)) with the lowest quartile (<47.8 MET-h/wk) in age-period 18-24 years (adjusted odds ratio (OR) 0.64, 95% confidence interval (CI) 0.40-1.02), and 45-64 years (OR 0.50, 95%CI 0.31-0.83) but not in age-period 25-44. Individuals who consistently engaged in overall PA at high levels (before age 65 years) had a 51% lower PD risk than those with low levels. Also, having participated in competitive sports prior to age 25 was inversely associated with PD (OR 0.53, 95% CI 0.31-0.91 for high level versus never). There was no association for measures of occupational physical activity though. CONCLUSION: The long prodromal stage of PD makes it difficult to conclude whether insidious disease leads to a reduction of physical activity years before motor symptom onset and PD diagnosis. However, sports activities and high levels of overall PA in youth appear protective unless they are markers for biologic or genetic factors that lower PD risk.
Authors: Ann D Cohen; Jennifer L Tillerson; Amanda D Smith; Timothy Schallert; Michael J Zigmond Journal: J Neurochem Date: 2003-04 Impact factor: 5.372
Authors: Beth E Fisher; Quanzheng Li; Angelo Nacca; George J Salem; Jooeun Song; Jeanine Yip; Jennifer S Hui; Michael W Jakowec; Giselle M Petzinger Journal: Neuroreport Date: 2013-07-10 Impact factor: 1.837
Authors: Ja K Gu; Luenda E Charles; Claudia C Ma; Michael E Andrew; Desta Fekedulegn; Tara A Hartley; John M Violanti; Cecil M Burchfiel Journal: Ann Epidemiol Date: 2016-08-28 Impact factor: 3.797
Authors: Sara Llamas-Velasco; Israel Contador; Antonio Méndez-Guerrero; Carmen Romero Ferreiro; Julián Benito-León; Alberto Villarejo-Galende; Félix Bermejo-Pareja Journal: Prev Med Rep Date: 2021-07-08
Authors: Clarissa L C Campêlo; Fernanda C Cagni; Diego de Siqueira Figueredo; Luiz G Oliveira; Antônio B Silva-Neto; Priscila T Macêdo; José R Santos; Geison S Izídio; Alessandra M Ribeiro; Tiago G de Andrade; Clécio de Oliveira Godeiro; Regina H Silva Journal: Front Aging Neurosci Date: 2017-06-20 Impact factor: 5.750